Demonstrates improved treatment outcomes in hepatocellular carcinoma using a phototherapy agent, suggesting a novel therapeutic strategy.
Hypoxia is a pervasive and spatially heterogeneous hallmark of hepatocellular carcinoma (HCC) that drives therapy resistance and motivates the use of hypoxia-activated prodrugs (HAPs) such as tirapazamine (TPZ). To synchronize...
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: